| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/07/2011 | WO2011039511A2 Agents, uses and methods |
| 04/07/2011 | WO2011039381A1 Antioxidants for use in therapy |
| 04/07/2011 | WO2011039365A1 Anti inflammatory 2-oxothiazoles and 2 -oxooxazoles |
| 04/07/2011 | WO2011039328A1 Administration of bifidobacterium breve during infancy to prevent inflammation later in life |
| 04/07/2011 | WO2011038662A1 Compounds as trpv1 blockers, pharmaceutical compositions and medical uses thereof |
| 04/07/2011 | WO2010135459A3 Brain delivery of insulin to treat systemic inflammation |
| 04/07/2011 | US20110083201 Compositions for and methods of grazyme b inhibition |
| 04/07/2011 | US20110082214 Process for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet |
| 04/07/2011 | US20110082211 Method for treating tinnitus aureum |
| 04/07/2011 | US20110082210 Fatty acid fibrate derivatives and their uses |
| 04/07/2011 | US20110082209 Novel Salts of (4--2-Methylphenyl)Carbonyl]Amino}-3-Methylphenyl)Acetic Acid |
| 04/07/2011 | US20110082206 Heteroatom containing substituted fatty acids |
| 04/07/2011 | US20110082204 N-alkylcarbonyl-amino acid ester and N-alkylcarbonyl-amino lactone compounds and their use |
| 04/07/2011 | US20110082192 Lipoic acid acylated salicylate derivatives and their uses |
| 04/07/2011 | US20110082186 Compositions for inhibiting gene expression and uses thereof |
| 04/07/2011 | US20110082181 Compounds as Lysophosphatidic Acid Receptor Antagonists |
| 04/07/2011 | US20110082179 Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water |
| 04/07/2011 | US20110082178 Methods of treating autoimmune and inflammatory diseases and disorders |
| 04/07/2011 | US20110082172 Pyrrolidinone carboxamide derivatives |
| 04/07/2011 | US20110082170 Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (vr1) and uses thereof |
| 04/07/2011 | US20110082166 Novel 4-benzhydryl-tetrahydro-pyridine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 04/07/2011 | US20110082164 Polycyclic compounds as lysophosphatidic acid receptor antagonists |
| 04/07/2011 | US20110082159 METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE |
| 04/07/2011 | US20110082155 Novel 2-Pyridone Compounds |
| 04/07/2011 | US20110082153 Gamma secretase modulators |
| 04/07/2011 | US20110082152 Therapeutic agents useful for treating pain |
| 04/07/2011 | US20110082151 Sulfonylurea modulators of endothelin receptor |
| 04/07/2011 | US20110082150 Headache pre-emption by dihydroergotamine treatment during headache Precursor events |
| 04/07/2011 | US20110082149 Metabolically inert antifolates for treating disorders of abnormal cellular proliferation and inflammation |
| 04/07/2011 | US20110082147 Substituted imidazotriazines |
| 04/07/2011 | US20110082145 Olopatadine compositions and uses thereof |
| 04/07/2011 | US20110082125 Topical Ophthalmic or Otic Solution Formulations Containing Moxifloxacin Hydrocholoride and Dexamethasone Phosphate |
| 04/07/2011 | US20110082120 Substituted thioacetic acid salicylate derivatives and their uses |
| 04/07/2011 | US20110082119 Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis |
| 04/07/2011 | US20110082117 Phenyl sulfonamides as modulators of ion channels |
| 04/07/2011 | US20110082116 Novel compounds as cannabinoid receptor ligands |
| 04/07/2011 | US20110082113 Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activity |
| 04/07/2011 | US20110082107 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 04/07/2011 | US20110082103 Anoectochilus SPP. polysaccharide extracts for stimulating growth of advantageous bacteria, stimuating release of granulocyte colony-Stimulating factor, modulating T helper cell type I, and/or modulating T helper cell type II and uses of the same |
| 04/07/2011 | US20110082102 Use of prebiotic galacto-oligosaccharides in the treatment of intestinal inflammation |
| 04/07/2011 | US20110082096 Gene and pathway and their use in methods and compositions for predicting onset or progression of autoimmune and/or autoinflammatory diseases |
| 04/07/2011 | US20110082087 Compounds for treating pain |
| 04/07/2011 | US20110082076 Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| 04/07/2011 | US20110082070 Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency |
| 04/07/2011 | US20110081432 Extracts of phyllanthus niruri |
| 04/07/2011 | US20110081424 Nutritional composition for bariatric surgery patients |
| 04/07/2011 | US20110081419 Ion exchange resin treated to control swelling |
| 04/07/2011 | US20110081411 Orally Administered Corticosteroid Compositions |
| 04/07/2011 | US20110081410 Therapeutic agent for local inflammation |
| 04/07/2011 | US20110081409 Selective inhibitors of histone deacetylase |
| 04/07/2011 | US20110081389 Composition comprising a mixture of active principles, and method of preparation |
| 04/07/2011 | US20110081384 Methods of wound care and treatment |
| 04/07/2011 | US20110081364 Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases |
| 04/07/2011 | US20110081361 Antibodies that bind interleukin-4 receptor |
| 04/07/2011 | US20110081344 Soluble zcytor 11 cytokine receptors |
| 04/07/2011 | US20110081340 Methods for treating disease using an anti-il-21 receptor antibody |
| 04/07/2011 | US20110081339 Methods of using il-17 receptor a antibodies |
| 04/07/2011 | US20110081338 Metabolically inert antifolates for treating disorders of abnormal cellular proliferation and inflammation |
| 04/07/2011 | US20110081329 Amino acid compositions |
| 04/07/2011 | US20110081321 Omentum as a source of stromal/stem cells and medical treatments using stromal/stem cells |
| 04/07/2011 | US20110081320 Treatment/Cure of Autoimmune Disease |
| 04/07/2011 | US20110081319 Composition and use of phyto-percolate for treatment of disease |
| 04/07/2011 | US20110081316 Pyrazole inhibitors of phosphatidylinositol 3-kinase |
| 04/07/2011 | US20110081301 Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate |
| 04/07/2011 | US20110079528 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 04/07/2011 | CA2782797A1 Anti inflammatory 2-oxothiazoles and 2-oxooxazoles |
| 04/07/2011 | CA2774040A1 2, 3-dihydro-1h-inden-2-yl urea derivatives and medical uses thereof |
| 04/07/2011 | CA2774027A1 Extracts of phyllanthus niruri |
| 04/07/2011 | CA2773618A1 2-pyridone compounds used as inhibitors of neutrophil elastase |
| 04/07/2011 | CA2771160A1 Process for preparing biphenyl imidazole compounds |
| 04/06/2011 | EP2305795A1 Method of collecting placental stem cells |
| 04/06/2011 | EP2305715A2 Monoclonal antibody to osteoprotegerin binding protein |
| 04/06/2011 | EP2305713A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305712A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305711A2 Methods for treating osteoarthitis pain by administering a nerve growth factor antagonist and compositions containing the same |
| 04/06/2011 | EP2305688A1 Novel aminoacids derivatives, their process of preparation and their therapeutical uses as MET inhibitors |
| 04/06/2011 | EP2305677A1 Alkyne-aryl-naphthyridin-4(1h)-one derivatives as type IV phosphodiesterase inhibitor |
| 04/06/2011 | EP2305668A1 8-oxy-quinoline derivatives as bradykinin B2 receptor modulators |
| 04/06/2011 | EP2305663A1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF alpha levels |
| 04/06/2011 | EP2305652A2 Trisubstituted quinazolinone derivatives as vanilloid antagonists |
| 04/06/2011 | EP2305314A2 Remodelling and glycoconjugation of antibodies |
| 04/06/2011 | EP2305313A2 Remodelling and glycoconjugation of interferon-alpha (IFNa) |
| 04/06/2011 | EP2305312A2 Remodelling and glycoconjugation of follicle-stimulating hormone (FSH) |
| 04/06/2011 | EP2305311A2 Glycoconjugation of peptides |
| 04/06/2011 | EP2305307A1 Analgesic anti-inflammatory preparation for external application |
| 04/06/2011 | EP2305305A1 Agent for induction/maintenance of remission |
| 04/06/2011 | EP2305283A1 Pharmaceutical compositions for treating dysregulated inflammatory diseases |
| 04/06/2011 | EP2305264A1 Spicamycin derivatives for use in decreasing or preventing pain |
| 04/06/2011 | EP2305248A1 Substituted phenethylsulfones and method of reducing tnf-alpha levels |
| 04/06/2011 | EP2305213A2 The treatment of small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 04/06/2011 | EP2305194A1 Sustained analgesia achieved with buprenorphine |
| 04/06/2011 | EP2305193A1 Sustained analgesia achieved with buprenorphine |
| 04/06/2011 | EP2305192A1 Sustained analgesia achieved with buprenorphine |
| 04/06/2011 | EP2305191A1 Sustained analgesia achieved with buprenorphine |
| 04/06/2011 | EP2303884A1 Adenine receptor ligands |
| 04/06/2011 | EP2303878A1 Aza-indoles and related compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 04/06/2011 | EP2303850A1 Novel potassium channel blockers and uses thereof |
| 04/06/2011 | EP2303840A2 Calcium ion channel modulators&uses thereof |
| 04/06/2011 | EP2303307A2 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
| 04/06/2011 | EP2303270A1 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |